| Literature DB >> 29858719 |
Caiyun Ma1, Kunfu Wang2, Hongda Ji1, Hongliang Wang1, Liangcai Guo3, Zhiyong Wang3, Han Ren3, Xishuai Wang1, Weijun Guan4.
Abstract
Amnion, which is usually discarded as medical waste, is considered as abundant sources for mesenchymal stem cells. In human and veterinary medicine, the multipotency of mesenchymal stem cells derived from amnion (AMSCs) together with their plasticity, self-renewal, low immunogenicity and nontumorigenicity characteristics make AMSCs a promising candidate cell for cell-based therapies and tissue engineering. However, up till now, the multipotential characteristics and therapeutic potential of AMSCs on preclinical studies remain uncertain. In this work, we successfully obtained AMSCs from Beijing duck embryos in vitro, and also attempted to detect their biological characteristics. The isolated AMSCs were phenotypically identified, the growth kinetics and karyotype were tested. Also, the cells were positive for MSCs-related markers (CD29, CD71, CD105, CD166, Vimentin and Fibronection), while the expression of CD34 and CD45 were undetectable. Additionally, AMSCs also expressed the pluripotent marker gene OCT4. Particularly, when appropriately induced, AMSCs could be induced to trans-differentiate into adipocytes, osteoblasts, chondrocytes and neurocytes in vitro. Together, these results demonstrated that the isolated AMSCs maintained their stemness and proliferation in vitro, which may be useful for future cell therapy in regenerative medicine.Entities:
Keywords: Amniotic mesenchymal stem cells; Beijing duck; Biological characteristics; Multiply differentiation
Mesh:
Year: 2018 PMID: 29858719 PMCID: PMC6280870 DOI: 10.1007/s10561-018-9701-6
Source DB: PubMed Journal: Cell Tissue Bank ISSN: 1389-9333 Impact factor: 1.522
Primer sequences used for RT-PCR
| Gene | Primers | Products (bp) |
|---|---|---|
| CD29 | F:5′-CAGAGAGCAACGCAGAGGTT-3′ | 226 |
| CD71 | F:5′-GAACCGGTACCTTGAGTGGG-3′ | 415 |
| CD166 | F:5′-AGGCAAAGCTAATAGTGGGCA-3′ | 209 |
| Vimentin | F:5′-GACCAGCTCACCAACGACAA-3′ | 395 |
| Fibronectin | F:5′-CCTCCAACTTCCATCGTGCT-3′ | 320 |
| PPAR-γ | F:5′-GCATCGACCAGCTAAACCCT-3′ | 259 |
| LPL | F:5′-TTTTCCTTACGGACGCCTGC-3′ | 369 |
| ATF4 | F:5′-CCCAGACTCCTACCTGGGAA-3′ | 239 |
| COL1A2 | F:5′-GGAATAGCTAGCCACCGACC-3′ | 421 |
| ACAN | F:5′-AGTGGCAGCTAATGTGGTCT-3′ | 547 |
| VIM | F:5′-ACGAAAGCGTTGCTGCTAAG-3′ | 218 |
| MAP2 | F:5′-ATCAATGGAGAGCTGTCGGC-3′ | 221 |
| GAPDH | F:5′-GAGGAGCTGCCCAGAACATT-3′ | 426 |
| CD34 | F:5′-CTCAACGAGTCCAACACCTG-3′ | 338 |
| CD45 | F:5′-CTCACCACACGCACTCTCAC-3′ | 350 |
Fig. 1Characterization of duck AMSCs in vitro. a Morphological characteristics of primary and sub-cultured AMSCs (bar = 50 μm). b Growth kinetics of AMSCs at P4, P10 and P18 with cell density in the Y-axis. c Karyotype analysis of duck AMSCs. Chromosomes at metaphase (left) and karyotype (right)
Fig. 2Detection of surface markers in AMSCs. a The AMSCs could express pluripotent marker gene OCT4 and MSC-associated markers by immunofluorescence stain (bar = 50 μm), DAPI, Blue. b mRNA expression levels of AMSCs markers were detected by RT-PCR, but the expression of CD34 and CD45 were not detected. c AMSCs at P4 were colabeled with surface antigens (CD29, CD166, CD71, CD105, OCT4), and the positive rates were all above 99% by flow cytometry analysis
Fig. 3Adipocyte, osteoblast differentiation of AMSCs (bar = 50 μm). a Numerous Lipid droplets, apparent in cytoplasm of induced cells, were positive for Oil Red staining. b RT-PCR was used to examine the expression of adipocyte marker genes PPAR-γ and LPL. c The differentiated cells cultured in OID for 14 days were monitored using Alizarin Red staining. d RT-PCR assays revealed osteoblast specific genes ATF4 and COL1A2 were expressed in the differentiated osteoblast
Fig. 4Chondrocyte and neurocyte differentiation of AMSCs (bar = 50 μm). a The differentiated chondrocyte was visualized by Alcian Blue staining. b The expression of chondrocyte-specific genes ACAN and VIM were analyzed by RT-PCR. c The differentiated cells cultured in NID for 14 days expressed MAP2 by immunocytochemistry. d RT-PCR detection of the neuronal marker MAP2 expression